[Cryptosporidiosis].
Verdon
R
R
Clinique des Maladies de l'Appareil Digestif, CHU Bichat, Paris.
Bellahsen
D
D
René
E
E
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy; D000828:Animal Population Groups / Q000469:parasitology; D000818:Animals; D003457:Cryptosporidiosis / Q000150:complications* / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology; D003458:Cryptosporidium / Q000276:immunology / Q000302:isolation & purification / Q000472:pathogenicity* / Q000502:physiology; D003967:Diarrhea / Q000188:drug therapy / Q000209:etiology; D006790:Host-Parasite Interactions; D006801:Humans; D007410:Intestinal Diseases / Q000150:complications; D015282:Octreotide / Q000627:therapeutic use; D009894:Opportunistic Infections / Q000150:complications* / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology; D013004:Somatostatin / Q000627:therapeutic use; D015572:Spiramycin / Q000627:therapeutic use; D014774:Virulence; D015215:Zidovudine / Q000627:therapeutic use
D015215:Zidovudine; D013004:Somatostatin; D015572:Spiramycin; D015282:Octreotide
La cryptosporidiose.